Bicycle Therapeutics plc

Healthcare · Biotechnology · United Kingdom

Last price 3.82 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 267.37M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company’s products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted imm...